PureTech Health

PureTech Health is a clinical-stage biopharmaceutical company that develops novel therapies to address unmet needs in a variety of disease areas. Their approach is centered on identifying and validating promising therapeutics with human efficacy, but that have key limitations hindering their full potential. They then unlock these therapeutics by using their proprietary technologies to improve key features like tolerability, bioavailability, and delivery methods. PureTech has a strong track record of clinical success, outperforming the biopharma industry average by 6x.

PureTech's portfolio of therapeutics includes a range of disease areas, including neuropsychiatric conditions, inflammatory and fibrotic diseases, and oncology. They are advancing their programs through a combination of internal development and collaborations with other companies. PureTech is committed to developing safe and effective therapies that will change the lives of patients with devastating diseases.

PureTech Health is a biotechnology company dedicated to developing new classes of medicine that address unmet patient needs in areas such as neuropsychiatric conditions, inflammatory and fibrotic diseases, and cancer. Their approach is centered on validated efficacy, clear patient benefit, and an efficient de-risked path to unlock these new therapeutic approaches, often by addressing limitations in existing treatments like poor bioavailability or tolerability. They accomplish this by leveraging their scientific expertise and collaborative network, along with proprietary technology platforms, to advance a robust pipeline of therapeutic candidates.

PureTech Health promotes a culture of collaboration and innovation, fostering a diverse and inclusive environment where employees can contribute their expertise to develop groundbreaking medicines for patients with devastating diseases. The company values teamwork, scientific rigor, and a commitment to making a positive impact on the world. PureTech emphasizes a focus on patient benefit and unlocking the full potential of new classes of medicine.